Luchtbrug Junior: the Next Step

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-6
SponsorRadboud University Medical Center

About this trial

Rationale:

The introduction of e-health in the monitoring and management of patients with chronic conditions can be beneficial and efficient. The introduction of an online monitoring and management tool, "Luchtbrug", for children 6-16 yrs of age with asthma while reducing 50% of visits to the outpatient clinic, results in similar or improved asthma control while reducing costs. It is highly likely that this concept of e-health is suitable for other chronic conditions. Therefore the aim of the study is to investigate the added value of online monitoring and management of children with preschool wheeze (2-6 yrs of age).

Objective: To assess whether the number of symptom free days can be improved using online monitoring and disease management via Luchtbrug Junior, while reducing the number of outpatient clinic visits by 50%

Study design: Prospective multicentre (n=6) randomised trial in which disease management via Luchtbrug Junior will be compared with usual care.

Follow-up: 12 months.

Study population: children aged 2-6 yrs with preschool wheezing (multiple episode of cough, wheeze and dyspnoea).

Intervention (if applicable): Children will be randomised into usual care (n=135) or partly online care via Luchtbrug Junior (n = 135)

Main study parameters/endpoints:

Primary objective: Number of symptom free days (SFDs) based on the TRACK questionnaire, during the last four weeks of the study (measured at 12 months).

Secondary objectives:

Healthcare consumption: unscheduled visits Emergency Department (ED) or outpatient clinic, unscheduled phone calls, hospital admissions) Questionnaires into: Quality of Life (QoL), cost-effectiveness (direct and indirect costs), self-management of patients, adherence to treatment, satisfaction of parents/caregivers.

Usual care consists of regular visits to the outpatient clinic every 3 months after starting the study. In between visits contact with the healthcare team is by telephone as needed. At 3, 6, 9 and 12 months, patients will be asked to complete the TRACK questionnaire.

Online care using Luchtbrug Junior will include visits to the outpatient clinic every 6 months after starting the study. In between visits, parents/caregivers of the patient will be asked to answer the digital version of TRACK questionnaire monthly, therefore the parents/caregivers will received email-reminders. Appropriate feedback on their TRACK-scores will be provided by their healthcare team within two working days. Any interventions such as adjustment of treatment are at the judgment of the treating pediatrician. Therapy adherence will be monitored during the study by using smart inhalers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children aged 2 to 6 years with a doctor's diagnosis of preschool wheeze

Children have an indication for regular follow-up of at least one year by a paediatrician because of respiratory symptoms;

Children are treated with inhaler medication, including inhaled corticosteroids;

At least one hospital admissions due to pulmonary symptoms before inclusion.

Disqualifiers

Underlying chronic cardiopulmonary or neuromuscular condition, or known recurrent aspirations;

Underlying syndromes associated with pulmonary comorbidities;

Prematurity <36 weeks after gestation;

Inability of parents/caregivers/caretakers to understand and/or read Dutch;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Luchtbrug Junior (online monitoring)

    Other intervention

    Online monitoring via Luchtbrug Junior will replace 50% of the outpatient visits. Children in the intervention group will be monitored online monthly by a digital version of TRACK.

  • Usual care

    Other intervention

    Routine outpatient clinical visits every 3 months.

Treatment groups

270 Participants
are divided into 2 treatment groups
Group A: Usual careActive comparator 1 intervention
Group B: Luchtbrug Junior (intervention)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change of Symptom free days / TRACK

Number of symptom free days (SFDs) based on the TRACK questionnaire during the last four weeks of the study (measured at 12 months). The amount of SFDs varies from 0 days to 30 days a month. A higher number indicates more symptom free days in the last four weeks of the study

Time frame
TRACK questionnaire at baseline, 3, 6 , 9 and 12 months

Secondary outcomes

1

Healthcare consumption

Healthcare consumption: * Number of unscheduled emergency department (ED) visits, * Number of unscheduled outpatient clinic visits, * Number of unscheduled phone calls, * Number of hospital admissions, and * Amount of medication prescriptions of systemic corticosteroids.

Time frame
Through study completion (follow-up of 12 months)
2

Paediatric caregivers quality of life (PACQLQ) (by Juniper)

This questionaire focuses in how parents/caregivers are limited in their own quality of life due to the child's disease. The questionnaire with a 1 week recall period consists of 13 items in two domains: emotional functioning and activity. Each items is scored using a 7-point scale, with 7 being indicative for optimal asthma related QoL. Items were all equally weighted and the overall PACQLQ score was measured by the mean of these item-scores. Minimal important difference for clinical relevance is 0.7 points

Time frame
Both groups will complete the PACQLQ at baseline, and 6 and 12 months
3

Self-management of parents/caregivers

The degree of self management will be assessed by a self-made questionnaire containing open questions and will be used for qualitative analyses. After completing the questionnaire, 10-15 parents/caregivers will be interviewed to obtain. The aim is to assess more detailed information about these self management skills and any change thereof during the study.

Time frame
At baseline and at 6 and 12 months
4

Cost-effectiveness

Cost-effectiveness: medical/direct costs and social/indirect costs by completing a cost diary

Time frame
At baseline and every 3 months for 1 year

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: